Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of HSV immunotherapy (HSVTI) for healthy adults aged 18-40 and people with recurrent genital herpes aged 18-60

    Not recruiting

    2 1
    Investigated Diseases:
    Belgium Estonia Germany Spain
  • Study Comparing High-Dose vs. Standard-Dose Influenza Vaccine for Preventing Flu in Older Adults

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Denmark
  • Study on the Safety and Immune Response of BIMERVAX as a COVID-19 Booster in Adolescents Aged 12 to 17 Years

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Spain
  • Study on the Effectiveness of Durvalumab and BCG in Treating High-Risk, Non-Muscle Invasive Bladder Cancer in Patients New to BCG Treatment

    Not recruiting

    3 1 1
    Investigated Diseases:
    Austria Belgium France Germany The Netherlands Poland +1
  • Study on the Immune Response and Safety of RSVPreF3 Vaccine in Adults 18-49 at Risk for Respiratory Syncytial Virus Compared to Adults 60 and Older

    Not recruiting

    3 1 1 1
    Germany
  • Study on Intradermal COVID-19 mRNA Vaccine (Tozinameran, Famtozinameran) for Elderly Patients Aged 75 and Older

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    The Netherlands
  • Study on the Immune Response and Safety of RSVPreF3 OA Vaccine Alone and with COVID-19 mRNA Vaccine in Adults Aged 50 and Above

    Not recruiting

    3 1 1 1
    Belgium The Netherlands Spain
  • Study on the Immune Response and Safety of RSVPreF3 OA Vaccine in Adults Aged 60+ with Respiratory Syncytial Virus Infections

    Not recruiting

    3 1 1 1
    Belgium Estonia Finland Germany Italy Poland +1
  • Study on the Safety and Immune Response of a 21-Valent Pneumococcal Conjugate Vaccine in Healthy Infants and Toddlers

    Not recruiting

    3 1 1 1
    Belgium Czechia Estonia Finland Germany Greece +3
  • Study on the Effectiveness and Safety of the VLA15 Vaccine for Preventing Lyme Disease in Healthy Individuals Aged 5 and Older

    Not recruiting

    3 1 1
    Finland Germany The Netherlands Poland Sweden
  • Study on the 9vHPV Vaccine for Preventing Oral HPV Infections in Men Aged 20-45

    Not recruiting

    3 1 1
    Investigated Diseases:
    Belgium Czechia France Germany Italy Spain
  • Study Comparing Intradermal and Intramuscular Rabies Vaccine Doses in Adults

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Belgium